Key result
Dihydropyridine receptor gene expression is reversibly suppressed by inhibitors of myogenesis such as TGF-beta-1 and ras oncogene, but is relatively insensitive to denervation.
DHPR gene induction is prevented by inhibitors of myogenesis, but shows relatively small changes in mRNA abundance during adaptation to denervation.
Animal data tie myogenic inhibitors to DHPR suppression; hypothesis-generating for excitation-contraction coupling, with no clinical implications yet.
To evaluate developmental and physiological signals that may influence expression of the dihydropyridine-sensitive "slow" Ca2+ channel, we analyzed dihydropyridine receptor (DHPR) mRNA abundance in mouse skeletal muscle. Using synthetic oligonucleotide probes corresponding to the rabbit skeletal muscle DHPR, a 6.5 kb DHPR transcript was identified in postnatal skeletal muscle and differentiated C2 or BC3H1 myocytes, but not cardiac muscle or brain. DHPR gene expression was reversibly suppressed by 0.4 nM transforming growth factor beta-1 or by transfection with a mutant c-H-ras allele, nominal inhibitors of myogenesis that block the appearance of slow channels and DHPR. In contrast, both BC3H1 and C2 myocytes containing the activated ras vector expressed the gene encoding the nicotinic acetylcholine receptor delta subunit, demonstrating that not all muscle-specific genes are extinguished by ras. Denervation stimulated DHPR gene expression less than 0.6-fold, despite 8-fold upregulation of delta-subunit mRNA and reciprocal effects on the skeletal and cardiac alpha-actin genes. Thus, DHPR gene induction is prevented by inhibitors of other muscle-specific genes, whereas, at most, relatively small changes in DHPR mRNA abundance occur during adaptation to denervation.
No takes yet. Share an insight, caveat, or question.
Shih et al. (1990) studied Myogenesis and denervation in skeletal muscle. Inhibitors of myogenesis (TGF-beta-1, ras oncogene) and denervation vs. Control cells or contralateral non-denervated muscles was evaluated on Dihydropyridine receptor (DHPR) mRNA abundance. Dihydropyridine receptor gene expression is reversibly suppressed by inhibitors of myogenesis such as TGF-beta-1 and ras oncogene, but is relatively insensitive to denervation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: